Adam Y. Holton - 15 Aug 2024 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
Chief People Officer
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
15 Aug 2024
Net transactions value
$0
Form type
4
Filing time
19 Aug 2024, 16:16:42 UTC
Previous filing
24 Jun 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +4,396 $0.000000 4,396 15 Aug 2024 Direct F1, F2
transaction GEHC Common Stock, par value $0.01 per share Award $0 +8,499 +193% $0.000000 12,895 15 Aug 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +13,293 $0.000000 13,293 15 Aug 2024 Common Stock, par value $0.01 per share 13,293 $85.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Award of restricted stock with respect to GE HealthCare common stock, of which 50% will vest on August 15, 2026, and 50% will vest on August 15, 2027, subject to certain conditions.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.